Auxilium Pharmaceuticals promotes James Tursi
Becomes chief medical officer having worked for US firm since 2009
Tursi entered the pharmaceutical industry in 2004 as a medical director for Procter and Gamble Pharmaceuticals. He worked on several products and therapeutic areas, including female sexual dysfunction, overactive bladder, and osteoporosis. His responsibilities included clinical development and medical affairs. He moved to GlaxoSmithKline Biologicals in 2006 and directed all Medical Affairs responsibilities for cancer vaccines in North America.
You may also like
Cleaning
Guardtech partner with Intense Pulsed Light innovators Biopulz to offer game-changing new cleanroom decontamination solution
New partnership will give Guardtech clients access to Biopulz’s mobile Eloane tower and integrated E-z̈o IPL decontamination system as part of their cleanroom installation projects
Analysis
Inspection readiness should be part of normal operations
For routine surveillance inspections, readiness cannot depend on receiving advance notice. Inspection readiness should be embedded in everyday operations, while recognising that preparation may need to become more intensive ahead of a known regulatory milestone
Pharmaceutical
T-Cypher Bio relocates to new Oxford facility to advance immune engager pipeline
The biotech firm has moved to a new facility at Abingdon Science Park, expanding its laboratory and tissue culture capabilities to support IND-enabling studies and the development of next-generation T-cell receptor-based therapeutics
Research & Development
TUM develops GNExT platform to identify potential Alzheimer’s drug candidates
The Technical University of Munich has developed a web-based tool that connects genome-wide association study data with biological networks, helping researchers identify disease mechanisms and potential drug repurposing opportunities